PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
290.00
0.00 (0.00%)
Apr 10, 2026, 2:33 PM WIB
Market Cap362.50B +63.8%
Revenue (ttm)166.62B +2.2%
Net Income2.94B +293.0%
EPS2.35 +293.0%
Shares Out1.25B
PE Ratio123.42
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume863,100
Average Volume2,666,650
Open292.00
Previous Close290.00
Day's Range284.00 - 298.00
52-Week Range130.00 - 382.00
Beta0.78
RSI47.66
Earnings DateApr 15, 2026

About IDX:DGNS

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology,... [Read more]

Sector Healthcare
Founded 2007
Employees 111
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DGNS
Full Company Profile

Financial Performance

In 2025, IDX:DGNS's revenue was 166.62 billion, an increase of 2.18% compared to the previous year's 163.07 billion. Earnings were 2.94 billion, an increase of 292.95%.

Financial Statements